trending Market Intelligence /marketintelligence/en/news-insights/trending/dkykwlqlofuq0oqz9aw9ia2 content esgSubNav
In This List

Theravance Biopharma CFO to resign

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Theravance Biopharma CFO to resign

Theravance Biopharma Inc. said Renee Gala will resign as senior vice president and CFO on Jan. 2, 2019.

Gala became CFO of the George Town, Cayman Islands-based pharmaceutical company in December 2014.

The company intends to initiate a search for a new CFO and Gala has agreed to stay on through her resignation date to assist in a smooth transition.

Theravance manufactures an injectable antibiotic VIBATIV to treat patients with infections.